National Health Investors, Inc. (NHI) Receives $80.14 Consensus Price Target from Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have earned an average rating of “Hold” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $80.14.

A number of analysts have weighed in on the stock. BidaskClub cut shares of National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Zacks Investment Research raised shares of National Health Investors from a “hold” rating to a “buy” rating and set a $90.00 target price on the stock in a report on Tuesday, September 5th. BMO Capital Markets reissued a “hold” rating and set a $80.00 target price on shares of National Health Investors in a report on Wednesday, October 18th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $82.00 target price on shares of National Health Investors in a report on Wednesday, October 4th.

WARNING: This report was originally posted by Community Financial News and is owned by of Community Financial News. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://www.com-unik.info/2017/10/29/national-health-investors-inc-nhi-receives-80-14-consensus-price-target-from-analysts.html.

In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the transaction, the insider now owns 21,228 shares in the company, valued at $1,693,994.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.19% of the stock is currently owned by corporate insiders.

Several institutional investors have recently added to or reduced their stakes in NHI. BlackRock Inc. grew its position in shares of National Health Investors by 6,473.4% during the first quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock worth $241,753,000 after acquiring an additional 3,277,930 shares during the last quarter. Vanguard Group Inc. grew its position in shares of National Health Investors by 3.3% during the first quarter. Vanguard Group Inc. now owns 6,219,436 shares of the real estate investment trust’s stock worth $451,717,000 after acquiring an additional 201,133 shares during the last quarter. Nuveen Asset Management LLC bought a new position in shares of National Health Investors during the first quarter worth about $11,559,000. State Street Corp grew its position in shares of National Health Investors by 8.5% during the second quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock worth $79,133,000 after acquiring an additional 78,355 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new position in shares of National Health Investors during the first quarter worth about $4,796,000. Institutional investors and hedge funds own 69.56% of the company’s stock.

Shares of National Health Investors (NHI) traded up 1.01% on Thursday, reaching $76.25. 256,191 shares of the company’s stock traded hands. The stock has a market capitalization of $3.13 billion, a PE ratio of 19.58 and a beta of 0.56. The company has a 50 day moving average of $77.98 and a 200-day moving average of $77.13. National Health Investors has a 52 week low of $66.31 and a 52 week high of $81.21.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.29 by ($0.36). The company had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The company’s revenue was up 14.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.22 earnings per share. Equities research analysts forecast that National Health Investors will post $3.86 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, September 29th will be issued a dividend of $0.95 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.98%. National Health Investors’s dividend payout ratio (DPR) is 97.69%.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

What are top analysts saying about National Health Investors Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for National Health Investors Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit